The UK devices sector is on a pathway to post-Brexit change, and the Medicines and Healthcare products Regulatory Agency (MHRA) is charting and steering the new course. It is a time of great ambition for the UK medtech sector, but is not without a certain concern on the part of industry about how the future will shape up, now the UK is no longer part of the EU.
Standing up a brand new regulatory system in the time available until 30 June 2023 has got to be the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?